THE EFFECT OF CLOBAZAM ON STEADY-STATE PLASMA-CONCENTRATIONS OF CARBAMAZEPINE AND ITS METABOLITES

被引:14
|
作者
MUNOZ, JJ [1 ]
DESALAMANCA, RE [1 ]
DIAZOBREGON, C [1 ]
TIMONEDA, FL [1 ]
机构
[1] HOSP UNIV SAN CARLOS,PORPHYRIA RES UNIT,E-28040 MADRID,SPAIN
关键词
D O I
10.1111/j.1365-2125.1990.tb03699.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Steady state metabolite/parent drug plasma ratios were measured in 15 epileptic patients on carbamazepine (CBZ) monotherapy and in seven patients treated with CBZ and clobazam (CLB). CBZ plasma concentrations did not differ between the two groups but patients also treated with CLB exhibited higher concentrations of CBZ‐10,11‐epoxide (CBZ‐E) and trans‐10,11‐dihydro‐10,11‐dihydroxy‐CBZ (CBZ‐T). Ratios between all of the metabolites of CBZ and the parent compound were higher in patients on polytherapy but the ratio between metabolites was not different. CLB comedication causes a moderate increase (about 1.5‐fold) in CBZ metabolism, probably by inducing its epoxidation. 1990 The British Pharmacological Society
引用
收藏
页码:763 / 765
页数:3
相关论文
共 50 条
  • [1] DAILY VARIATIONS IN STEADY-STATE PLASMA-CONCENTRATIONS OF CARBAMAZEPINE AND ITS METABOLITES IN EPILEPTIC CHILDREN
    HARTLEY, R
    FORSYTHE, WI
    MCLAIN, B
    NG, PC
    LUCOCK, MD
    [J]. CLINICAL PHARMACOKINETICS, 1991, 20 (03) : 237 - 244
  • [2] NEUROLEPTIC EFFECT ON DESIPRAMINE STEADY-STATE PLASMA-CONCENTRATIONS
    NELSON, JC
    JATLOW, PI
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1980, 137 (10): : 1232 - 1234
  • [3] STEADY-STATE PLASMA-CONCENTRATIONS OF PROPAFENONE - CHIRALITY AND METABOLISM
    VOLZ, M
    MITROVIC, V
    SCHLEPPER, M
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (07) : 370 - 375
  • [4] THE RELATIONSHIP OF ALPRAZOLAM DOSE TO STEADY-STATE PLASMA-CONCENTRATIONS
    CIRAULO, DA
    ANTAL, EJ
    SMITH, RB
    OLSON, DR
    GOLDBERG, DA
    RAND, EH
    RASKIN, RB
    PHILLIPS, JP
    SHADER, RI
    GREENBLATT, DJ
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (01) : 27 - 32
  • [5] STEADY-STATE PLASMA-CONCENTRATIONS OF MIANSERIN AND ITS MAJOR ACTIVE METABOLITE, DESMETHYLMIANSERIN
    OTANI, K
    SASA, H
    KANEKO, S
    KONDO, T
    FUKUSHIMA, Y
    [J]. THERAPEUTIC DRUG MONITORING, 1993, 15 (02) : 113 - 117
  • [6] THE EFFECT OF HYDRALAZINE ON STEADY-STATE PLASMA-CONCENTRATIONS OF METOPROLOL IN PREGNANT HYPERTENSIVE WOMEN
    LINDEBERG, S
    HOLM, B
    LUNDBORG, P
    REGARDH, CG
    SANDSTROM, B
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (02) : 131 - 135
  • [7] AUTOINDUCTION AND STEADY-STATE PHARMACOKINETICS OF CARBAMAZEPINE AND ITS MAJOR METABOLITES
    KUDRIAKOVA, TB
    SIROTA, LA
    ROZOVA, GI
    GORKOV, VA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (06) : 611 - 615
  • [8] LEVORPHANOL - PHARMACOKINETICS AND STEADY-STATE PLASMA-CONCENTRATIONS IN PATIENTS WITH PAIN
    DIXON, R
    CREWS, T
    INTURRISI, C
    FOLEY, K
    [J]. RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1983, 41 (01): : 3 - 17
  • [9] PREDICTION OF STEADY-STATE VERAPAMIL PLASMA-CONCENTRATIONS IN CHILDREN AND ADULTS
    WAGNER, JG
    ROCCHINI, AP
    VASILIADES, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (02) : 172 - 181
  • [10] PLASMA STEADY-STATE CONCENTRATIONS OF HYDROXYLATED METABOLITES OF CLOMIPRAMINE
    LINNOILA, M
    INSEL, T
    KILTS, C
    POTTER, WZ
    MURPHY, DL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (02) : 208 - 211